Full article: Correction

Views

CrossRef citations to date

Altmetric

This article refers to:

Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies

Article Title: Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies

Authors: Bruzzese, A., Martino, E.A., Labanca, C., Mendicino, F., Lucia, E., Olivito, V., Neri, A., Morabito, F., Vigna, E., & Gentile M.

Journal: Expert Opinion on Investigational Drugs

DOI: http://dx.doi.org/10.1080/13543784.2024.2309873

The article title was published online with the incorrect drug name “BGB-1417” instead of “BGB-11417”. Now, it has been replaced with the below article title in the original version.

Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Correction

Information for

Open access

Opportunities

Help and information

Correction

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature